How does low-molecular-weight heparin compare with vitamin K antagonists for long-term treatment of individuals with symptomatic venous thromboembolism?

2017 ◽  
Keyword(s):  
Molecular Weight ◽  
Venous Thromboembolism ◽  
Vitamin K ◽  
Low Molecular Weight Heparin ◽  
Vitamin K Antagonists ◽  
Term Treatment ◽  
Low Molecular Weight ◽  
Long Term Treatment

Long-Term Use of Different Doses of Low-Molecular-Weight Heparin Versus Vitamin K Antagonists in the Treatment of Venous Thromboembolism

2010 ◽  
Vol 24 (5) ◽  
pp. 628-639 ◽  
Author(s):  
A. Romera-Villegas ◽  
M.A. Cairols-Castellote ◽  
R. Vila-Coll ◽  
X. Martí-Mestre ◽  
E. Colomé ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Venous Thromboembolism ◽  
Vitamin K ◽  
Low Molecular Weight Heparin ◽  
Vitamin K Antagonists ◽  
Low Molecular Weight ◽  
Different Doses
Sign in / Sign up

Export Citation Format

Share Document